These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35549842)

  • 21. COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?
    Das BB
    Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33352654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical observations of COVID-19 infection in patients with chronic thromboembolic pulmonary hypertension.
    Kamenskaya OV; Loginova IY; Klinkova AS; Lomivorotov VV; Chernyavsky AM
    Kardiologiia; 2021 Jul; 61(6):28-34. PubMed ID: 34311685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.
    Savale L; Habibi A; Lionnet F; Maitre B; Cottin V; Jais X; Chaouat A; Artaud-Macari E; Canuet M; Prevot G; Chantalat-Auger C; Montani D; Sitbon O; Galacteros F; Simonneau G; Parent F; Bartolucci P; Humbert M
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31537700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
    COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
    Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of COVID-19 pandemic on pulmonary hypertension: What have we learned?
    Hinojosa W; Cristo-Ropero MJ; Cruz-Utrilla A; Segura de la Cal T; López-Medrano F; Salguero-Bodes R; Pérez-Olivares C; Navarro B; Ochoa N; Arribas Ynsurriaga F; Escribano-Subias P
    Pulm Circ; 2022 Oct; 12(4):e12142. PubMed ID: 36238968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care.
    Norderfeldt J; Liliequist A; Frostell C; Adding C; Agvald P; Eriksson M; Lönnqvist PA
    Acta Anaesthesiol Scand; 2021 Jul; 65(6):761-769. PubMed ID: 33728633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
    Aggarwal A; Shrivastava A; Kumar A; Ali A
    J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Update on Pulmonary Hypertension in Coronavirus Disease-19 (COVID-19).
    Mishra A; Lal A; Sahu KK; George AA; Martin K; Sargent J
    Acta Biomed; 2020 Nov; 91(4):e2020155. PubMed ID: 33525228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
    J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes in COVID-19 among patients with hypertension in the Philippine CORONA Study.
    Espiritu AI; Sucaldito MSFP; Ona DID; Apor ADAO; Sy MCC; Anlacan VMM; Jamora RDG
    Eur J Med Res; 2023 Feb; 28(1):62. PubMed ID: 36732874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation.
    Olivas-Martínez A; Cárdenas-Fragoso JL; Jiménez JV; Lozano-Cruz OA; Ortiz-Brizuela E; Tovar-Méndez VH; Medrano-Borromeo C; Martínez-Valenzuela A; Román-Montes CM; Martínez-Guerra B; González-Lara MF; Hernandez-Gilsoul T; Herrero AG; Tamez-Flores KM; Ochoa-Hein E; Ponce-de-León A; Galindo-Fraga A; Kershenobich-Stalnikowitz D; Sifuentes-Osornio J
    PLoS One; 2021; 16(2):e0245772. PubMed ID: 33534813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.
    Bellan M; Soddu D; Balbo PE; Baricich A; Zeppegno P; Avanzi GC; Baldon G; Bartolomei G; Battaglia M; Battistini S; Binda V; Borg M; Cantaluppi V; Castello LM; Clivati E; Cisari C; Costanzo M; Croce A; Cuneo D; De Benedittis C; De Vecchi S; Feggi A; Gai M; Gambaro E; Gattoni E; Gramaglia C; Grisafi L; Guerriero C; Hayden E; Jona A; Invernizzi M; Lorenzini L; Loreti L; Martelli M; Marzullo P; Matino E; Panero A; Parachini E; Patrucco F; Patti G; Pirovano A; Prosperini P; Quaglino R; Rigamonti C; Sainaghi PP; Vecchi C; Zecca E; Pirisi M
    JAMA Netw Open; 2021 Jan; 4(1):e2036142. PubMed ID: 33502487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the COVID-19 Pandemic on Pulmonary Hypertension Patients: Insights from the BNP-PL National Database.
    Mamzer A; Waligora M; Kopec G; Ptaszynska-Kopczynska K; Kurzyna M; Darocha S; Florczyk M; Mroczek E; Mularek-Kubzdela T; Smukowska-Gorynia A; Wrotynski M; Chrzanowski L; Dzikowska-Diduch O; Perzanowska-Brzeszkiewicz K; Pruszczyk P; Skoczylas I; Lewicka E; Blaszczak P; Karasek D; Kusmierczyk-Droszcz B; Mizia-Stec K; Kaminski K; Jachec W; Peregud-Pogorzelska M; Doboszynska A; Gasior Z; Tomaszewski M; Pawlak A; Zablocka W; Ryczek R; Widejko-Pietkiewicz K; Kasprzak JD
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
    Jutant EM; Jaïs X; Girerd B; Savale L; Ghigna MR; Perros F; Mignard X; Jevnikar M; Bourlier D; Prevot G; Tromeur C; Bauer F; Bergot E; Dauphin C; Favrolt N; Traclet J; Soumagne T; De Groote P; Chabanne C; Magro P; Bertoletti L; Gueffet JP; Chaouat A; Goupil F; Moceri P; Borie R; Fadel E; Wolkenstein P; Brillet PY; Simonneau G; Sitbon O; Humbert M; Montani D
    Am J Respir Crit Care Med; 2020 Sep; 202(6):843-852. PubMed ID: 32437637
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 in Adults With Congenital Heart Disease.
    Broberg CS; Kovacs AH; Sadeghi S; Rosenbaum MS; Lewis MJ; Carazo MR; Rodriguez FH; Halpern DG; Feinberg J; Galilea FA; Baraona F; Cedars AM; Ko JM; Porayette P; Maldonado J; Sarubbi B; Fusco F; Frogoudaki AA; Nir A; Chaudhry A; John AS; Karbassi A; Hoskoppal AK; Frischhertz BP; Hendrickson B; Bouma BJ; Rodriguez-Monserrate CP; Broda CR; Tobler D; Gregg D; Martinez-Quintana E; Yeung E; Krieger EV; Ruperti-Repilado FJ; Giannakoulas G; Lui GK; Ephrem G; Singh HS; Almeneisi HM; Bartlett HL; Lindsay I; Grewal J; Nicolarsen J; Araujo JJ; Cramer JW; Bouchardy J; Al Najashi K; Ryan K; Alshawabkeh L; Andrade L; Ladouceur M; Schwerzmann M; Greutmann M; Meras P; Ferrero P; Dehghani P; Tung PP; Garcia-Orta R; Tompkins RO; Gendi SM; Cohen S; Klewer S; Hascoet S; Mohammadzadeh S; Upadhyay S; Fisher SD; Cook S; Cotts TB; Aboulhosn JA
    J Am Coll Cardiol; 2021 Apr; 77(13):1644-1655. PubMed ID: 33795039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»).
    Tarlovskaya EI; Arutyunov AG; Konradi AO; Lopatin YM; Rebrov AP; Tereshchenko SN; Chesnikova AI; Hayrapetyan HG; Babin AP; Bakulin IG; Bakulina NV; Balykova LA; Blagonravova AS; Boldina MV; Vaisberg AR; Galyavich AS; Gomonova VV; Grigorieva NY; Gubareva IV; Demko IV; Evzerikhina AV; Zharkov AV; Kamilova UK; Kim ZF; Kuznetsova TY; Lareva NV; Makarova EV; Malchikova SV; Nedogoda SV; Petrova MM; Pochinka IG; Protasov KV; Protsenko DN; Ruzanau DY; Sayganov SA; Sarybaev AS; Selezneva NM; Sugraliev AB; Fomin IV; Khlynova OV; Chizhova OY; Shaposhnik II; Shсukarev DA; Abdrahmanova AK; Avetisian SA; Avoyan HG; Azarian KK; Aimakhanova GT; Ayipova DA; Akunov AC; Alieva MK; Aparkina AV; Aruslanova OR; Ashina EY; Badina OY; Barisheva OY; Batchayeva AS; Bitieva AM; Bikhteyev IU; Borodulina NA; Bragin MV; Budu AM; Burygina LA; Bykova GA; Vagapova KR; Varlamova DD; Vezikova NN; Verbitskaya EA; Vilkova OE; Vinnikova EA; Vustina VV; Gаlova EA; Genkel VV; Gorshenina EI; Gostishev RV; Grigorieva EV; Gubareva EY; Dabylova GM; Demchenko AI; Dolgikh OY; Duyshobayev MY; Evdokimov DS; Egorova KE; Ermilova AN; Zheldybayeva AE; Zarechnova NV; Zimina YD; Ivanova SY; Ivanchenko EY; Ilina MV; Kazakovtseva MV; Kazymova EV; Kalinina YS; Kamardina NA; Karachenova AM; Karetnikov IA; Karoli NA; Karpov OV; Karsiev MK; Кaskaeva DS; Kasymova KF; Kerimbekova ZB; Kerimova AS; Kim ES; Kiseleva NV; Klimenko DA; Klimova AV; Kovalishena OV; Kolmakova EV; Kolchinskaya TP; Kolyadich MI; Kondriakova OV; Konoval MP; Konstantinov DY; Konstantinova EA; Kordukova VA; Koroleva EV; Kraposhina AY; Kriukova TV; Kuznetsova AS; Kuzmina TY; Kuzmichev KV; Kulchoroeva CK; Kuprina TV; Kouranova IM; Kurenkova LV; Kurchugina NY; Kushubakova NA; Levankova VI; Levin MЕ; Lyubavina NA; Magdeyeva NA; Mazalov KV; Majseenko VI; Makarova AS; Maripov AM; Marusina AA; Melnikov ES; Moiseenko NB; Muradova FN; Muradyan RG; Myshak AO; Nikitina NM; Ogurlieva BB; Odegova AA; Omarova YM; Omurzakova NA; Ospanova SO; Pahomova EV; Petrov LD; Plastinina SS; Pogrebetskaya VA; Polyakov DS; Ponomarenko EV; Popova LL; Prokofeva NA; Pudova IA; Rakov NA; Rakhimov AN; Rozanova NA; Serikbolkyzy S; Simonov AA; Skachkova VV; Soloveva DV; Soloveva IA; Sokhova FM; Subbotin AK; Sukhomlinova IM; Sushilova AG; Tagayeva DR; Titojkina YV; Tikhonova EP; Tokmin DS; Tolmacheva AA; Torgunakova MS; Trenogina KV; Trostianetckaia NA; Trofimov DA; Tulichev AA; Tursunova AT; Ulanova ND; Fatenkov OV; Fedorishina OV; Fil TS; Fomina IY; Fominova IS; Frolova IA; Tsvinger SM; Tsoma VV; Cholponbaeva MB; Chudinovskikh TI; Shevchenko OA; Sheshina TV; Shishkina EA; Shishkov KY; Sherbakov SY; Yausheva EA; Musaelian SN; Belenkov YN; Arutyunov GP
    Kardiologiia; 2021 Sep; 61(9):20-32. PubMed ID: 34713782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.